Cas:42429-20-9 Acetamido(phenyl)acetic acid manufacturer & supplier

We serve Chemical Name:Acetamido(phenyl)acetic acid CAS:42429-20-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Acetamido(phenyl)acetic acid

Chemical Name:Acetamido(phenyl)acetic acid
CAS.NO:42429-20-9
Synonyms:Benzeneacetic acid, α-(acetylamino)-;(S)-N-Acetyl-2-phenylglycine;(S)-2-Acetamido-2-phenylacetic acid;Acetamido(phenyl)acetic acid;2-(acetylamino)-2-phenylacetic acid
Molecular Formula:C10H11NO3
Molecular Weight:193.199
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:439.2±38.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.555
PSA:66.40000
Exact Mass:193.073898
LogP:0.59

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzeneacetic acid, α-(acetylamino)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(acetylamino)-2-phenylacetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzeneacetic acid, α-(acetylamino)- Use and application,Acetamido(phenyl)acetic acid technical grade,usp/ep/jp grade.


Related News: “The acquisition of Vanamali Organics represents the next stage of this investment strategy,” Wavelength CEO Iftach Seri said in a statement. ” We are delighted to add their talented team and advanced development and manufacturing capabilities to Wavelength, and we expect they will be important contributors to our global supply chain network and our rapidly growing custom development and manufacturing services business.” Imidazole-epichlorohydrin copolymer manufacturers Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. Methyl 4-aminobenzoate suppliers For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. 2-Ethoxyethyl ether vendor & factory.